Patients with pulmonary arterial hypertension(PAH) cannot stop taking the phosphodiesterase inhibitor. As a result, NTG is contraindicated
a) Contraindications for nitrate therapy
b) Indications for phosphodiesterase inhibitors
c) Side effects of calcium channel blockers
d) Complications of cardiac catheterization
